RCB Project Research Scientist I Eliglustat 2026

RCB Project Research Scientist I Recruitment 2026: Overview

Regional Centre for Biotechnology (RCB) is hiring a Project Research Scientist-I (Non-Medical) for a cancer immunotherapy project in Faridabad, Haryana. The study focuses on Eliglustat, an FDA-approved inhibitor, and its possible use against breast and oral cancer. Professor Dr. Avinash Bajaj is the principal investigator for this project.

The project looks at repurposing and validating an existing drug. In simple terms, the research asks whether Eliglustat could have a use beyond the purpose for which it was approved. The notice identifies its target as UDP-Glucose Ceramide Glucosyltransferase, abbreviated as UGCG, and places the work in the context of cancer immunotherapy.

Service Conditions and Caveats

• Project engagement: Your appointment is tied to the named Eliglustat study. The notice describes a project position, so you should read its terms as a research engagement for that study.
• Initial tenure: The stated appointment period is three months. Keep this initial term in mind when considering the offer and planning your availability.
• Extension: The notice allows an extension for one year. It describes this as an extension option, rather than an automatic part of the initial appointment.

Application Submission Notes

The walk-in venue is Regional Centre for Biotechnology, 3rd Milestone, Faridabad-Gurgaon Expressway, NCR Biotech Science Cluster, Faridabad-121001, Haryana. The stated interview time is 3:00 PM, and the campus address in the notice is the place to attend in person.

For questions about this project opening, contact the principal investigator at bajaj@rcb.res.in. This email is given for queries; the application route stated in the notice is a walk-in interview.